ETF Objective

The Fund seeks to track the investment results of an index composed if large-, mid- and small-capitalization emerging market equities. The Fund invests at least 90% of its assets in the component securities of the Underlying Index and in investments that have economic characteristics similar to such securities.

Stock Chart

as of 4:10 PM ET 10/18/2021

Performance

  • 1 Week
  • +2.17%
  • 1 Month
  • +0.97%
  • 3 Months
  • -2.74%
  • 1 Yr Return
  • +16.72%
  • 5 Yr Return
  • +39.37%

Sector Breakdown

Technology 23.97%
Financials 20.12%
Consumer Services 11.28%
Consumer Goods 10.15%
Industrials 9.61%
Basic Materials 8.06%
Health Care 5.04%
Oil & Gas 4.95%
Telecommunications 2.38%
Utilities 2.10%

Geographic Exposure

China 29.00%
Taiwan 15.41%
Korea 13.57%
India 12.55%
Brazil 5.14%
South Africa 3.23%
Saudi Arabia 3.06%
Russian Federation 2.72%
Hong Kong 2.29%
Mexico 1.95%
Thailand 1.91%
Malaysia 1.52%
Indonesia 1.25%
Poland 0.79%
United Arab Emirates 0.75%
Qatar 0.71%
Philippines 0.67%
Kuwait 0.61%
Chile 0.50%
Turkey 0.42%
Greece 0.27%
Cyprus 0.25%
Luxembourg 0.25%
Netherlands 0.25%
Hungary 0.24%
United States 0.23%
Colombia 0.17%
Unidentified 0.14%
Czech Republic 0.11%
Peru 0.10%
Egypt 0.10%
Cayman Islands 0.08%
Pakistan 0.07%
Singapore 0.06%
Argentina 0.06%
Isle of Man 0.03%
Australia 0.01%
Belgium 0.01%
Uruguay 0.01%
Spain 0.01%

Top 10 Holdings

Symbol Company Name % Of Assets
INFY Infosys Ltd ORD 0.85%
VALE3 Vale SA ORD 0.82%
JD JD.Com Inc DR 0.72%

ETF Overview

Sponsor BlackRock
iNav Ticker BZ3X
Inception Date 10/18/2012
Name iShares:Core MSCI EmMkts
CUSIP 46434G103
Prospectus Date 12/30/2020

ETF Characteristics

Market Capitalization 127.32 B
Total Net Assets 78.53 K
Management Fee 0.13%
Administration Fee 0.00%
Asset Class Equity
Sub Asset Class Emerging Markets Funds
Number Of Holdings 2,646
Expense Ratio 0.14
Dividend 0.47
Dividend Frequency Semiannual

LATEST NEWS

Recent Articles from TheStreet

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

What to know about Cloudflare's Upcoming IPO

Investing in the Cloud: Consider Cloudflare and Digital Ocean

Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.

Philip Morris International Lead

Philip Morris Ekes Out Third-Quarter Earnings Beat

Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.

The Travelers Companies Lead

Travelers Posts Third Quarter Earnings Beat on Record Net Written Premiums

Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Stock Market Today: Dow Gains On Earnings Strength; Housing Starts Disappoint

Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.

Procter & Gamble Is Under Siege From an Activist Investor

Procter & Gamble Stock Slips After Q1 Earnings Beat; 2022 Forecast Unchanged

Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.

No More Tears for Johnson & Johnson?

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.

Stock Market Lead

Stocks Gain, SEC GameStop Report, Rent The Runway IPO - 5 Things You Must Know

Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.